Molecular Markers and Death From Prostate Cancer
نویسندگان
چکیده
منابع مشابه
Molecular markers and death from prostate cancer.
BACKGROUND Current methods to assess the prognosis of prostate cancer at the time of diagnosis are limited. OBJECTIVE To determine whether molecular markers of cell cycle regulation (bcl-2 and p53) and angiogenesis (beta-3 integrin, vascular endothelial growth factor, and microvessel density) are associated with increased long-term risk for death among men with prostate cancer. DESIGN Obser...
متن کاملProstate Cancer, Prostate Cancer Death, and Death from Other Causes, Among Men with Metabolic Aberrations
BACKGROUND Few previous studies of metabolic aberrations and prostate cancer risk have taken into account the fact that men with metabolic aberrations have an increased risk of death from causes other than prostate cancer. The aim of this study was to calculate, in a real-life scenario, the risk of prostate cancer diagnosis, prostate cancer death, and death from other causes. METHODS In the M...
متن کاملEpigenetic Markers for Molecular Detection of Prostate Cancer
Prostate cancer is a highly prevalent malignancy, which is clinically silent but curable while organ-confined. Because available screening methods show poor sensitivity and specificity, the development of new molecular markers is warranted. Epigenetic alterations, mainly promoter hypermethylation of cancer-related genes, are common events in prostate cancer and might be used as cancer biomarker...
متن کاملMolecular markers in prostate cancer. Part I: predicting lethality.
Assessing the lethality of 'early,' potentially organ-confined prostate cancer (PCa) is one of the central controversies in modern-day urological clinical practice. Such cases are often considered for radical 'curative' treatment, although active surveillance may be equally appropriate for many men. Moreover, the balance between judicious intervention and overtreatment can be difficult to judge...
متن کاملUrine markers and prostate cancer
Prostate cancer (PCa) is globally the most common cancer in men, with an estimated prevalence of more than two million cases. Given the poor success rate in treating advanced PCa, intervention in early stages may reduce the progression of a small, localized carcinoma to a large metastatic lesion, thereby reducing disease-related deaths. Urine is readily available and can be used to detect eithe...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Internal Medicine
سال: 2009
ISSN: 0003-4819
DOI: 10.7326/0003-4819-150-9-200905050-00005